Skip to main content

Click, Shop, Savor: Animal Model Market Set to Soar Past USD 4.44 Billion by 2031

The global Animal Model market size is expected to reach USD 4.44 billion by 2031 and exhibit a CAGR of 7.8% in the forecast period (2024−2031), according to Skyquest’s latest research report. The increased demand for preclinical testing in pharmaceutical and biotechnology research, rising investments in drug development and toxicology studies, the growing prevalence of chronic diseases necessitating animal-based research, advancements in genetic engineering and precision medicine requiring animal models, and the expansion of research in areas like neuroscience and regenerative medicine that heavily rely on animal models is fueling the market’s growth.

Westford,USA, Feb. 21, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Animal Model  market, the continued development of alternative in vitro methods and the growing emphasis on reducing animal testing, a shift towards more ethical and humane animal research practices, the increasing use of genetically modified animal models and CRISPR technology, and a rising focus on creating diverse and representative animal models for a broader range of diseases, are the trends that aid in the market’s growth.

Browse in-depth TOC on “Animal Model Market”

  • Pages – 157
  • Tables – 63
  • Figures – 75

An animal model is a non-human species used in biomedical research to study a specific disease or biological process. Animal models are chosen because they share similarities with humans in their anatomy, physiology, and response to pathogens. This allows researchers to extrapolate the results of animal model studies to understand human physiology and disease better.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/animal-model-market

Prominent Players in Animal Model Market

  • Biocytogen Pharmaceuticals Co. Ltd.
  • Charles River Laboratories International Inc.
  • Covance
  • Crown Bioscience
  • Envigo
  • Genoway
  • Harbour BioMed Co. Ltd.
  • Hera Testing Laboratories Inc.
  • Janvier Labs
  • JSR Corporation
  • Ozgene Holdings Pty Ltd.
  • PerkinElmer Inc. (Horizon Discovery Group PLC)
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • Trans Genic Inc.
  • Inotiv, Inc.
  • Envigo RMS
  • Vivotion
  • Wuxi AppTec
  • Medpace
  • Crown Bioscience
  • Envigo

Rodents Demand to Grow Substantially in the Forecast Period

Rodents dominates the global online market as they share a significant genetic similarity with humans, making them valuable for studying various diseases and drug responses. This similarity allows researchers to extrapolate findings to human applications more effectively.

Individual Consumer is the Leading Application Segment

The development of new drugs and therapies is a primary driver for the use of animal models. Researchers use animals to test new pharmaceutical compounds’ safety, efficacy, and potential side effects. This application segment is critical for pharmaceutical companies in bringing new drugs to market.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/animal-model-market

North America is the leading Market Due to Technological Advancements

Region-wise, North America is one of the largest growing markets with a huge emphasis on technological advancements. The United States has a robust regulatory framework that supports the use of animal models in research, which is essential for the pharmaceutical industry. Regulatory agencies such as the FDA require preclinical animal testing for drug development and approval.

A recent report thoroughly analyzes the major players operating within the Animal Model market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Animal Model.

Key Developments in Animal Model Market

  • Charles River Laboratories International Inc., a prominent player in the animal model market, announced the acquisition of Distributed Bio, Inc., a biotechnology company specializing in the discovery and optimization of therapeutic antibodies. This acquisition aimed to enhance Charles River’s capabilities in antibody discovery and engineering, providing comprehensive solutions to its customers.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/animal-model-market

Key Questions Answered in Animal Model Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Paresthesia Treatment Market

Global Neonatal Intensive Care Market

Global Recombinant Vaccines Market 

Global Bacterial Cell Culture Market

Global Collateral Ligament Stabilizer System Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.